Guggenheim Capital LLC Surmodics Inc Transaction History
Guggenheim Capital LLC
- $14 Billion
- Q3 2024
A detailed history of Guggenheim Capital LLC transactions in Surmodics Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 11,269 shares of SRDX stock, worth $447,153. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,269
Previous 11,269
-0.0%
Holding current value
$447,153
Previous $473,000
7.61%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding SRDX
# of Institutions
126Shares Held
11.8MCall Options Held
1.4KPut Options Held
8.6K-
Black Rock Inc. New York, NY1.17MShares$46.5 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.04MShares$41.3 Million0.01% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA989KShares$39.2 Million14.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA804KShares$31.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY753KShares$29.9 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $556M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...